These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32035727)

  • 41. Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling.
    Berceli SA; Jiang Z; Klingman NV; Pfahnl CL; Abouhamze ZS; Frase CD; Schultz GS; Ozaki CK
    J Vasc Surg; 2004 May; 39(5):1084-90. PubMed ID: 15111865
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pyrogallol abates VSMC migration via modulation of Caveolin-1, matrix metalloproteinase and intima hyperplasia in carotid ligation mouse.
    Ma YD; Thiyagarajan V; Tsai MJ; Lue SI; Chia YC; Shyue SK; Weng CF
    Environ Toxicol Pharmacol; 2016 Dec; 48():63-75. PubMed ID: 27768988
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of matrix metalloproteinase (MMP) 2 and MMP-9 in soft tissue sarcoma.
    Yang HK; Jeong KC; Kim YK; Jung ST
    Clin Orthop Surg; 2014 Dec; 6(4):443-54. PubMed ID: 25436070
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
    Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
    Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of matrix metalloproteinases (MMPs) and their tissue inhibitors in human myometrial smooth muscle cells by TGF-beta1.
    Ma C; Chegini N
    Mol Hum Reprod; 1999 Oct; 5(10):950-4. PubMed ID: 10508223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Co-overexpression of human tissue kallikrein 1 and human metalloproteinase 1 tissue inhibitor inhibits neointima formation in the rat artery after balloon angioplasty].
    Yu HZ; Zhang F; Zhu PL; Pan W; Huang SJ; Xiang H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 May; 44(5):436-42. PubMed ID: 27220581
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency.
    Saito S; Trovato MJ; You R; Lal BK; Fasehun F; Padberg FT; Hobson RW; Durán WN; Pappas PJ
    J Vasc Surg; 2001 Nov; 34(5):930-8. PubMed ID: 11700497
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endothelial nitric oxide synthase protects aortic allografts from the development of transplant arteriosclerosis.
    Lee PC; Wang ZL; Qian S; Watkins SC; Lizonova A; Kovesdi I; Tzeng E; Simmons RL; Billiar TR; Shears LL
    Transplantation; 2000 Mar; 69(6):1186-92. PubMed ID: 10762225
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios.
    Pérez P; Kwon YJ; Alliende C; Leyton L; Aguilera S; Molina C; Labra C; Julio M; Leyton C; González MJ
    Arthritis Rheum; 2005 Sep; 52(9):2751-60. PubMed ID: 16142742
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of leflunomide and cyclosporine on aortic allograft chronic rejection in the rat.
    MacDonald AS; Sabr K; MacAuley MA; McAlister VC; Bitter-Suermann H; Lee T
    Transplant Proc; 1994 Dec; 26(6):3244-5. PubMed ID: 7998130
    [No Abstract]   [Full Text] [Related]  

  • 51. Expression of matrix metalloproteinases in cardiac allograft vasculopathy and its attenuation by anti MMP-2 ribozyme gene transfection.
    Tsukioka K; Suzuki Ji; Fujimori M; Wada Y; Yamaura K; Ito Ki; Morishita R; Kaneda Y; Isobe M; Amano J
    Cardiovasc Res; 2002 Dec; 56(3):472-8. PubMed ID: 12445888
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effects of tissue inhibitor of matrix metalloproteinases-4 on the activities of matrix metalloproteinases and collagen of artery: experiment with rats].
    Zu LY; Guo YH; Chen L; Li Q; Yan H; Gao W
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(7):472-5. PubMed ID: 16677575
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of combined rapamycin/cyclosporine on the changes in pro-fibrotic gene expression that occur during the development of allograft vasculopathy in rats, compared with cyclosporine or rapamycin in isolation.
    Murphy GJ; Bicknell GR; Nicholson ML
    Transpl Int; 2003 May; 16(5):347-53. PubMed ID: 12759727
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nitric oxide inhibition increases aortic wall matrix metalloproteinase-9 expression.
    Eagleton MJ; Peterson DA; Sullivan VV; Roelofs KJ; Ford JA; Stanley JC; Upchurch GR
    J Surg Res; 2002 May; 104(1):15-21. PubMed ID: 11971672
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of platelet-derived growth factor ligands in rat cardiac allograft vasculopathy and fibrosis.
    Tuuminen R; Nykänen A; Keränen MA; Krebs R; Alitalo K; Koskinen PK; Lemström KB
    Transplant Proc; 2006 Dec; 38(10):3271-3. PubMed ID: 17175246
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Matrix metalloproteinases. Their role in degenerative chronic diseases of abdominal aorta.
    Palombo D; Maione M; Cifiello BI; Udini M; Maggio D; Lupo M
    J Cardiovasc Surg (Torino); 1999 Apr; 40(2):257-60. PubMed ID: 10350113
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Green tea catechins inhibit neointimal hyperplasia in a rat carotid arterial injury model by TIMP-2 overexpression.
    Cheng XW; Kuzuya M; Sasaki T; Kanda S; Tamaya-Mori N; Koike T; Maeda K; Nishitani E; Iguchi A
    Cardiovasc Res; 2004 Jun; 62(3):594-602. PubMed ID: 15158152
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinases-1 in the liver: efficient protection against T-cell lymphoma and colon carcinoma metastasis.
    Elezkurtaj S; Kopitz C; Baker AH; Perez-Cantó A; Arlt MJ; Khokha R; Gansbacher B; Anton M; Brand K; Krüger A
    J Gene Med; 2004 Nov; 6(11):1228-37. PubMed ID: 15390257
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin-like growth factor binding protein related protein 1 knockdown attenuates hepatic fibrosis via the regulation of MMPs/TIMPs in mice.
    Ren JJ; Huang TJ; Zhang QQ; Zhang HY; Guo XH; Fan HQ; Li RK; Liu LX
    Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):38-47. PubMed ID: 30243878
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Latanoprost's effects on TIMP-1 and TIMP-2 expression in human ciliary muscle cells.
    Anthony TL; Lindsey JD; Weinreb RN
    Invest Ophthalmol Vis Sci; 2002 Dec; 43(12):3705-11. PubMed ID: 12454040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.